AAAAAA

   
Results: 1-11 |
Results: 11
Intensive use of intravascular ultrasound during coronary angioplasty. A six-month campaign
Authors: Johansson, P Lunden, M Ekstrom, L Grip, L Wennerblom, B
Citation: P. Johansson et al., Intensive use of intravascular ultrasound during coronary angioplasty. A six-month campaign, SC CARDIOVA, 35(2), 2001, pp. 75-79
Coagulation activity and clinical outcome in unstable coronary artery disease
Authors: Oldgren, J Linder, R Grip, L Siegbahn, A Wallentin, L
Citation: J. Oldgren et al., Coagulation activity and clinical outcome in unstable coronary artery disease, ART THROM V, 21(6), 2001, pp. 1059-1064
There is no effect on remodeling of vascular wall 4 weeks after local delivery of antithrombin in a porcine model of coronary overstretching
Authors: Schersten, F Bjornheden, T Wiklund, O Grip, L
Citation: F. Schersten et al., There is no effect on remodeling of vascular wall 4 weeks after local delivery of antithrombin in a porcine model of coronary overstretching, CORON ART D, 12(1), 2001, pp. 31-36
Early assessment of long-term risk with continuous ST-segment monitoring among patients with unstable coronary syndromes. Results from 1-year follow-up in the TRIM study
Authors: Abrahamsson, P Andersen, K Grip, L Wallentin, L Dellborg, M
Citation: P. Abrahamsson et al., Early assessment of long-term risk with continuous ST-segment monitoring among patients with unstable coronary syndromes. Results from 1-year follow-up in the TRIM study, J ELCARDIOL, 34(2), 2001, pp. 103-108
Appropriateness of percutaneous transluminal coronary angioplasty in stable and unstable angina pectoris. A review
Authors: Grip, L
Citation: L. Grip, Appropriateness of percutaneous transluminal coronary angioplasty in stable and unstable angina pectoris. A review, SC CARDIOVA, 34(5), 2000, pp. 454-460
Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty - Results of the glycoprotein receptor antagonist patency evaluation (GRAPE) pilot study
Authors: van den Merkhof, LFM Zijlstra, F Olsson, H Grip, L Veen, G Bar, FWHM van den Brand, MJBM Simoons, ML Verheugt, FWA
Citation: Lfm. Van Den Merkhof et al., Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty - Results of the glycoprotein receptor antagonist patency evaluation (GRAPE) pilot study, J AM COL C, 33(6), 1999, pp. 1528-1532
The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease
Authors: Linder, R Oldgren, J Egberg, N Grip, L Larson, G Siegbahn, A Wallentin, L
Citation: R. Linder et al., The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease, EUR HEART J, 20(7), 1999, pp. 506-518
Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease
Authors: Oldgren, J Linder, R Grip, L Siegbahn, A Wallentin, L
Citation: J. Oldgren et al., Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease, EUR HEART J, 20(22), 1999, pp. 1657-1666
The impact of an end-point committee in a large multicentre, randomized, placebo-controlled clinical trial - Results with and without the end-point committee's final decision on end-points
Authors: Naslund, U Grip, L Fischer-Hansen, J Gundersen, T Lehto, S Wallentin, L
Citation: U. Naslund et al., The impact of an end-point committee in a large multicentre, randomized, placebo-controlled clinical trial - Results with and without the end-point committee's final decision on end-points, EUR HEART J, 20(10), 1999, pp. 771-777
Thrombin inhibitors suppress the thrombin-thrombomodulin-mediated generation of activated protein C
Authors: Linder, R Blomback, M Egberg, N Grip, L
Citation: R. Linder et al., Thrombin inhibitors suppress the thrombin-thrombomodulin-mediated generation of activated protein C, THROMB RES, 95(2), 1999, pp. 117-125
Local delivery of antithrombin inhibits platelet deposition after balloon injury in a porcine coronary model
Authors: Schersten, F Bjornheden, T Emanuelsson, H Wiklund, O Grip, L
Citation: F. Schersten et al., Local delivery of antithrombin inhibits platelet deposition after balloon injury in a porcine coronary model, CORON ART D, 9(12), 1998, pp. 823-829
Risultati: 1-11 |